Sionna Therapeutics Funding & Investors
Boston, MA
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
sionnatx.comTotal Amount Raised: $292,000,000
Sionna Therapeutics Funding Rounds
IPO
Unknown
Series C
$182,000,000
Series C Investors
Enavate SciencesRA Capital ManagementAtlas VenturePerceptive AdvisorsOrbiMed AdvisorsCystic Fibrosis Foundation - Connecticut ChapterThe Rise FundViking Global InvestorsQ Healthcare HoldingsT. Rowe PriceSeries B
$110,000,000
Series B Investors
OrbiMed AdvisorsT. Rowe PriceAtlas VentureRA Capital ManagementCystic Fibrosis Foundation - Connecticut ChapterThe Rise Fund
Funding info provided by Diffbot.